Ebola.com & EbolaVirus.com Listed for Sale
The Ebola virus has been in the news for the last few months due to the serious outbreak in western Africa. I think the frequency of news articles is only going to increase now that the first case of Ebola has been diagnosed in the United States. I also believe that more people are going to be searching Google and Bing for information about Ebola as a result. With this news, I thought it was interesting to see two exact match Ebola virus domain names come on the market.
For quite some time, I’ve known the founder of the company that owns Ebola.com, Blue String Ventures. The company has owned Ebola.com since 2008. Now that Ebola is in the news even more, I reached out to him to find out some details about Ebola.com, and he let me know the company recently put the domain name up for sale. DigitalDNA is the domain broker, and the company has not established an asking price for Ebola.com.
At the present time, there is a one page website on Ebola.com. The landing page provides a bit of information about the Ebola virus, and it also provides a few links to articles. In addition, there are affiliate links to Amazon and a supplement website, but I do not have any revenue details. There seems to be quite a bit of traffic coming to this domain name, although the owner is unsure of the accuracy of his traffic counter.
Another Ebola virus related domain name, EbolaVirus.com, is also currently listed for sale on Flippa. According to the sale listing, EbolaVirus.com earned $772 in revenue in August of 2014. That was a substantial increase in revenue from prior months, which makes sense due to the amount of news coverage. This auction has a buy it now price of $22,000, and bidders may place lower bids on the domain name if they wish.
Longterm, I have no idea what the prospects are for these domain names or other domain names related to the Ebola virus. I would assume a pharmaceutical company might want to own them, but it seems that the pharma companies involved in finding a cure or a vaccine may not need to spend too much on marketing given the demand these drugs would have when or if they become commercially available.
I will be keeping my eye on these two sales and will post an update if I see that they sold.
(Full disclosure, I know the owners of these two domain names, but I have no involvement in either sale).
Reach out to Elliot: Twitter | Google + | Facebook | Email